Our Impact

Why GLA?

Global Lyme Alliance (GLA) has awarded over $16 million towards our Lyme and tick-borne disease research program to date. GLA-funded projects have led to unprecedented advances in such areas as prevention, diagnosis and the treatment of tick-borne illnesses.

GLA-funded researchers—who were the first to prove the existence of the previously disputed chronic Lyme condition—have decoded the Lyme genome, discovered how the disease can survive antibiotic therapy, and now understand far more about what makes the Lyme bacterium different than any other type of infection. Learn more about our research.

Read Our Latest Brochure

Global Lyme Alliance is the leading 501(c)(3) whose mission is to cure Lyme and other tick-borne diseases through innovation research, awareness, and empowering the patient voice. Learn more about who we are, what we do, and why we matter. Click below to read or download our latest WHY GLA brochure.

New! Case for Support Documents

Pediatric Lyme Disease Case for Support

Protecting our most vulnerable patients.

Lyme is the fastest growing tick-borne illness in the US, with children being most at risk. While most children recover from the disease, today’s treatments are limited beyond the standard course of antibiotics which are not effective for about 3 out of every 10 patients. What's worse, most pediatric Lyme cases are missed. This can be tragic. Learn more in our case for support.

Lyme and Mental Heath Case for Support

GLA is working to improve care for Lyme patients by funding research to find answers, give patients solutions to their problems, and raise awareness around the issue of Lyme and mental health. We need meaningful research efforts to understand this better, to raise awareness, and to treat patients better. Learn more about our groundbreaking research on Lyme and Mental Health.

Diagnostics Case for Support

GLA seeks to transform the tick-borne disease diagnostics space by supporting innovative strategies that will better detect Lyme and other tick-borne diseases, preventing suffering from missed or delayed Lyme disease diagnosis. Recognizing the critical need for developing new and improved diagnostic tests. Learn more about the research we are supporting.

Feel free to download and share our case for support documents. Questions? Email info@gla.org

Research Partnerships

GLA has forged significant partnerships with the academic community who support research. Most notably, the organization partnered in 2007 with the Lyme Disease Association to fund and create the first research center for the study of persistent Lyme at Columbia University Medical Center in New York City.

For the past decade, GLA has funded innovative and promising research at top-tier universities across the United States, including Johns Hopkins University, Washington University in St Louis, Texas A&M, Northeastern University, University of Missouri, University of California San Francisco, University of Pennsylvania and Stony Brook University.

GLA announced a partnership with Ionica Sciences in October 2017 to develop an accurate Lyme disease diagnostic test.

Research Results

GLA has identified and funded groundbreaking research in the areas of diagnostics, therapeutics, and basic understanding of the Lyme bacterium: